# Cardinal Health, Inc. (CAH) FY2026 YTD Q3 P&L / Income Statement

- Company: Cardinal Health, Inc. (CAH)
- Period: 2025-07-01 to 2026-03-31
- Filing: Q3 FY2026 10-Q, filed 2026-04-30, accession number 0000721371-26-000018
- Page: https://plicit.ai/financials/cah/fy2026-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/cah-fy2026-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2025-07-01 through 2026-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 190,576,000,000 US dollars
- **Cost of products sold**: 183,362,000,000 US dollars
- **Gross margin**: 7,214,000,000 US dollars
- **Operating costs, net of other operating items (calculated)**: 5,330,000,000 US dollars
- **Operating earnings**: 1,884,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 264,000,000 US dollars
- **Earnings/(loss) before income taxes**: 1,620,000,000 US dollars
- **Provision for income taxes**: 315,000,000 US dollars
- **Net earnings/(loss)**: 1,305,000,000 US dollars
- **Pharmaceutical and Specialty Solutions**: 175,985,000,000 US dollars
- **Cost of product sold**: 9,591,000,000 US dollars
- **Other Segments**: 5,071,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 4,507,000,000 US dollars
- **Restructuring and employee severance**: 66,000,000 US dollars
- **Amortization and other acquisition-related costs**: 348,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 243,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: 173,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 7,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 190,647,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Corporate**: negative 71,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmaceutical and Specialty Solutions costs**: 173,847,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Cost of product sold costs**: 9,483,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Other Segments costs**: 4,547,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 815,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.32 B; to noncontrolling interests: −$11.00 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/cah/fy2026-ytd-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/cah-fy2026-ytd-q3-revenue-by-geography-sankey.png

Income statement for 2025-07-01 through 2026-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 190,576,000,000 US dollars
- **Cost of products sold**: 183,362,000,000 US dollars
- **Gross margin**: 7,214,000,000 US dollars
- **Operating costs, net of other operating items (calculated)**: 5,330,000,000 US dollars
- **Operating earnings**: 1,884,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 264,000,000 US dollars
- **Earnings/(loss) before income taxes**: 1,620,000,000 US dollars
- **Provision for income taxes**: 315,000,000 US dollars
- **Net earnings/(loss)**: 1,305,000,000 US dollars
- **UNITED STATES**: 189,370,000,000 US dollars
- **Non-US**: 1,277,000,000 US dollars
- **Distribution, selling, general and administrative expenses**: 4,507,000,000 US dollars
- **Restructuring and employee severance**: 66,000,000 US dollars
- **Amortization and other acquisition-related costs**: 348,000,000 US dollars
- **Acquisition-related cash and share-based compensation costs**: 243,000,000 US dollars
- **Impairments and (gain)/loss on disposal of assets, net**: 173,000,000 US dollars
- **Litigation (recoveries)/charges, net**: negative 7,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 190,647,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 71,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.32 B; to noncontrolling interests: −$11.00 M.